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Abstract
Objective: The purpose of this study was to assess if screen time in U.S. adolescents is
positively associated with evidence of fatty liver disease (steatosis and/or fibrosis) on FibroScan
technology and to test the hypothesis that being overweight or obese mediates this relationship.
Methods: The analysis used cross-sectional data from 12–17-year-old participants (n = 612) in
the 2017-2018 National Health and Nutrition Examination Survey (NHANES) to evaluate the
association between self-reported average daily screen time and the presence of liver steatosis
and/or fibrosis using FibroScan. Adjusted logistic regression analysis was performed to describe
the independent association between screen time and the presence of liver disease. Additionally,
mediation analysis was conducted by sequentially regressing obesity on screen time and
regressing liver disease on screen time and obesity.
Results: Overall, 38.2% of adolescents had evidence of liver disease on FibroScan. A
significant effect of daily screen time was seen on liver disease status, t (610) = 2.74, p =.006.
Adolescents with evidence of liver steatosis and/or fibrosis spent an average of 38.4 minutes
(95% CI, 11.0 - 65.8) per day longer on screens than those who did not have liver disease.
Sobel’s test (ab = .128, Z=2.053, p=.040) confirmed that overweight/obesity significantly
mediates the relationship between screen time and liver disease. After accounting for the
mediating effect of overweight/obese status, screen time has a small, but not statistically
significant direct effect on fatty liver disease.
Discussion: Average daily screen time in adolescents affects liver steatosis and/or fibrosis
indirectly through obesity.
Keywords: Overweight, Obesity, Steatosis, Fibrosis, Fibroscan
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The Relationship between Screen Time, Weight Status, and Fatty Liver Disease in
U.S. Adolescents, a Cross-Sectional Study Using NHANES, 2017-2018
The prevalence of obesity (BMI 95th percentile and above for age and sex) in adolescents
in the United States (U.S.) has been consistently and dramatically increasing from 6.1% in the
early 1970s to 21.2% in 2018 (Fryar, Carroll, & Afful, 2020). Increasing adolescent obesity has
led to obesity-related cardiovascular and metabolic diseases at earlier ages that affect nearly
every organ, including the liver. The prevalence of fatty liver disease is estimated to be 7.6-9.6%
in children generally and 34.2% in obese children (Le Garf et al., 2021). Fatty liver disease
progresses along a continuum from steatosis (simple fatty liver), non-alcoholic steatohepatitis or
NASH (fat with inflammation), liver fibrosis, cirrhosis, and hepatocellular cancer. Previously
termed nonalcoholic fatty liver diseases (NAFLD), many researchers and clinicians are using the
term metabolic-associated fatty liver diseases (MAFLD) to accurately reflect the etiology of the
spectrum of fatty liver abnormalities. It is estimated that 23% of all adolescents with MAFLD
have NASH and that 9% of adolescents with NASH have advanced fibrosis or cirrhosis (Le Garf
et al., 2021). Beyond obesity, other risk factors for pediatric MAFLD include male sex, Hispanic
ethnicity, and increasing age.
With a global prevalence of 3-10%, MAFLD is currently the leading form of chronic
liver disease in adolescents (Le Garf et al., 2021). MAFLD is an independent risk factor for type
2 diabetes and cardiovascular disease. Liver disease developed early in life can result in
significant morbidity and mortality in adulthood. Along with increasing rates of obesity and
rising MAFLD prevalence in adolescents, there is a concerning trend of increasing liver
transplant registrations of younger patients with NASH; this reflects a cohort-based ‘adipose
wave effect’ as MAFLD progresses in severity over the life course (Shingina et al., 2019). In the
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decades ahead, MAFLD will likely surpass viral etiologies to become the leading cause of end
stage liver disease among all age groups.
Although obesity is strongly associated with MAFLD, it is neither necessary nor
sufficient for its development. It is estimated that MAFLD can be found in 8-16% of non-obese
children (Brecelj & Orel, 2021). The pathogenesis of MAFLD has been studied in adults more
than in adolescents. Liver biopsies show different histological patterns of lipid accumulations in
pediatric and adult patients, although the etiological significance of this and its effect on disease
progression is unclear. The currently accepted ‘multiple hit’ hypothesis proposes that genetics,
prenatal exposures, and environmental factors may program metabolic and endocrine responses,
predisposing to the development of MAFLD. The development of obesity and insulin resistance
then contribute to fatty acid accumulation in the liver. The modernization of lifestyle factors,
including dietary changes, reduced physical activity, and increased sedentary behaviors may be
contributing to the increasing prevalence of both obesity and MAFLD.
Adolescents in the U.S. are spending more time than ever watching television and online
videos. A large national study found that teens view an average of seven and a half hours of
screen time a day, not including screen use at school or the use of computers for homework
(Rideout & Robb, 2019). The COVID-19 pandemic intensified usage of screen-based
technology due to stay at home mandates and remote online learning. In the Adolescent Brain
Cognitive Development (ABCD) cross-sectional study, average daily screen usage more than
doubled during the pandemic in comparison to prepandemic estimates (Nagata et al., 2022).
Early studies suggest lifting of mandates may not reduce screen time usage back to prepandemic
levels (Werling, Walltza, & Drechsler, 2021). As screening platforms increase, total screen time
usage is likely to remain high.
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Increasing use of screens is associated with adverse social, mental, and physical health
outcomes, including poor self-esteem, depression, and obesity (Barnett et al., 2018). While
adolescent screen time has been evaluated in terms of metabolic biomarkers for hyperglycemia,
hypercholesterolemia, and hypertension (Hardy et al., 2010), the use of serum biomarkers to
screen for MAFLD may underestimate its prevalence in young obese people and overestimate it
in the general pediatric population (Le Garf et al., 2021). Although liver biopsy is the gold
standard to assess liver steatosis and fibrosis, it is expensive, invasive, has limited sensitivity,
and is not practical for follow-up assessments. No study to date has evaluated the association
between screen time and the presence of MAFLD using liver imaging modalities. FibroScan
uses ultrasound measures of controlled attenuation parameter (CAP) to assess liver steatosis (fat)
and ultrasound combined with vibration-controlled transient elastography (TE) to assess liver
fibrosis (stiffness) and is a non-invasive, evidence-based method of assessing liver disease in
pediatric patients (Chen & Pan, 2022). The purpose of this study was to examine the association
of screen time with liver steatosis and/or fibrosis using FibroScan technology in a nationally
representative sample of adolescents aged 12 to 17 as mediated by overweight/obesity. It was
hypothesized that screen time will positively predict liver steatosis and/or fibrosis using
FibroScan technology and that being overweight or obese will mediate this relationship.
Methods
Study Design and Population
This study utilized existing data from the 2017-2018 National Health and Nutrition
Examination Survey (NHANES). NHANES is a cross-sectional survey with stratified,
multistage, clustered probability sampling design including individuals who are representative of
the general, non-institutionalized population, aged two months and older (CDC, 2017-2018).
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The eligible population for the current study of the association between the independent variable
average daily screen time (continuous) and the dependent variable liver disease (yes/no
[referent]) were adolescents 12 to 17 years of age (n = 907). Exclusion criteria were known selfreported history of viral or autoimmune liver disease, serological evidence of Hepatitis B or C,
and missing or incomplete data for screen time, BMI, FibroScan exam, or covariates age,
race/ethnicity, sex, family income, or physical activity for a final study population (n = 612)
(Figure 1). Analysis for mediation by weight category (overweight/obese yes vs.
overweight/obese no[referent]) was conducted for the association of screen time with liver
disease. Participants were questioned about their history of liver disease, and all denied
knowledge of fibrosis, cirrhosis, viral hepatitis, and autoimmune liver disorders. Two
participants were aware they have fatty liver disease, which was confirmed on FibroScan
examination. No participants were found to have serological evidence of acute or chronic
hepatitis B or C.
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Figure 1
Selection of Study Participants from Adolescents Aged 12-17, NHANES 2017-2018
Eligible participants aged 12-17
NHANES (2017-2018), n = 907

Incomplete liver exams, n = 159
Missing BMI, n = 47
Missing screen time responses, n = 56
Missing family income to poverty, n = 101
Missing physical activity data, n = 57

Study participants,
n = 612

Data Collection
NHANES combines in home health interviews with standardized health examinations.
Questions of demographic and personal information (age, sex, race/ethnicity, and family income)
were asked directly to adolescents aged sixteen and older; a proxy responded for younger
adolescents and for older children unable to answer the questions. The family income to poverty
ratio (FIPR) was calculated using annual Department of Health and Human Services poverty
guidelines. The FIPR was analyzed by quartiles with the highest quartile serving as the referent
category. Questions regarding screentime and physical activity were asked in the home for
individuals aged 16 and older and in the Mobile Examination Center (MEC) for adolescents aged
12 to 15. All adolescents answered these questions themselves unless they were unable, in
which case a proxy was used. For screen time, adolescents were asked two questions about their
screen use in the last 30 days, “On average how many hours per day did you sit and watch TV or
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videos?” and “On average, how many hours per day did you use a computer or play computer
games outside of school? Include PlayStation, Nintendo DS, or other portable video games.”
These hours were combined to form an average daily screentime variable (continuous). Physical
activity was assessed by asking “During the past 7 days, on how many days were you physically
active for a total of at least 60 minutes per day?” and analyzed as a continuous variable. Physical
exam included measurement of weight and height to generate a body mass index (BMI). BMI
was then characterized as overweight/obese if it was at the 85th percentile or above for age and
sex according to CDC growth charts (National Center for Health Statistics, n.d.).
Liver evaluation was performed using FibroScan® Model 502 V2 Touch by trained
NHANES health technicians in the MEC according to manufacturer guidelines. Data from all
12–17-year-olds with completed elastography examination (fasting time at least three hours,
minimum 10 complete stiffness measures, and liver stiffness interquartile (IQRe) range/ median
stiffness <30%) were analyzed. FibroScan uses transient elastography (TE) to derive median
liver fibrosis and controlled attenuation parameter (CAP) to derive median liver steatosis.
Cutoffs of 7.3 E/kPa on TE measurement and 233 dB/m on CAP measurement were used to
denote the presence of clinically significant fibrosis and steatosis, respectively, in accordance
with current literature in pediatric liver disease evaluation (Chen & Pan, 2022). A dichotomous
variable Liver Disease (yes/no[referent]), was created for the presence of fibrosis and/or steatosis
on FibroScan exam.
Statistical Procedures
Univariate analysis. Descriptive statistics for continuous variables (screen time
(hours/day), physical activity (days/week) and age (years)) included measures of centrality
(mean) and dispersion (standard deviation) and graphical displays (histograms). Frequency
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distributions were examined for categorical variables (liver disease, weight status, sex,
race/ethnicity, and FIPR quartiles).
Bivariate analysis. Across two liver disease status groups, associations were tested by
Student’s two-sample t-test for continuous variables (screen time, physical activity, and age) and
chi-square test for categorical variables (liver disease, weight status, sex, race/ethnicity, and
FIPR quartiles).
Multivariable analysis. Adjusted logistic regression analysis was performed to describe
the independent association between screen time and liver status. A series of logistic regression
analyses were carried out to test the hypothesis that overweight/obesity status mediates the
relationship between screen time and liver disease. One model regressed liver disease on screen
time. Another model regressed obesity on screen time. A third model regressed liver disease on
screen time and obesity. Adjustments were made for age, sex, race/ethnicity, FIPR quartiles, and
physical activity for all regressions. The indirect effect of daily screen time on liver disease
through overweight/obesity status was determined by the product of coefficients method (a*b).
Sobel’s test was used to determine whether overweight/obesity mediates the association between
daily screen time and the presence of liver steatosis and/or fibrosis in adolescents. All tests were
two-sided and conducted at the α = 0.05 level of significance. Analyses were performed using
Statistical Package for the Social Sciences (SPSS) IBM Corp. Released 2020. IBM SPSS
Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp.
Results
Overall, 234 (38%) adolescents had evidence of liver disease (steatosis and/or fibrosis)
on FibroScan (Table 1).
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Table 1
Results of FibroScan Testing for Liver Disease - Fibrosis and Steatosis, Participants Aged 12-17
Years, NHANES 2017-2018*
Fibrosis present

Fibrosis absent

Total

n (% of total)

n (% of total)

n (% of total)

25 (4.1)

200 (32.7)

225 (36.8)

9 (1.5)

378 (61.8)

387 (63.2)

34 (5.6)

578 (94.4)

612 (100)

Steatosis present
n (% of total)
Steatosis absent
n (% of total)
Total
n (% of total)

*Cutoffs of 7.3 E/kPa on TE measurement and 233 dB/m on CAP measurement were used to denote the presence of
clinically significant fibrosis and steatosis, respectively (Chen & Pan, 2022).

In the sample population, the average age of adolescents was 14.7 years (SD = 1.7)
(Table 2). The mean screen time for all participants was 5.8 hours per day (SD = 2.8). A
sizeable proportion of adolescents in the study were overweight or obese (43%). Overall, there
was a fairly equal distribution between male (48%) and female (52%) participants. NonHispanic Whites (34%) comprised the largest racial/ethnic group, followed by Hispanic (24%)
and non-Hispanic Black (22%).
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Table 2
Characteristics of NHANES 2017-2018 Cross-Sectional Study Participants Aged 12-17 Years,
Overall, and by Liver Disease (Steatosis and/or Fibrosis) on FibroScan Imaging
Overall
N = 612

Liver Disease
N = 234
(38.2%)

Screen time (hours/day) mean ± SD

5.75 ± 2.82

6.15 ± 2.78

No Liver
Disease
N = 378
(61.8%)
5.51 ± 2.82

Physical activity (days/week) mean ± SD

3.79 ± 2.24

3.71 ± 2.25

3.83 ± 2.24

263 (42.97)
349 (57.03)

165 (70.51)
69 (29.49)

98 (25.93)
280 (74.07)

295 (48.20)
317 (51.80)
14.72 ± 1.66

127 (54.27)
107(45.73)
14.84 ± 1.54

168 (44.44)
210 (55.56)
14.65 ± 1.73

205 (33.50)
134 (21.90)
147 (24.02)
63 (10.29)
63 (10.29)

65 (27.78)
53 (22.65)
64 (27.35)
24 (10.26)
28 (11.97)

140 (37.04)
81 (21.43)
83 (21.96)
39 (10.32)
35 (9.26)

Characteristic

Weight status, n (%)
Overweight/obese
Not overweight/obese
Gender, n (%)
Male
Female
Age (years at screening) mean ± SD
Race/ethnicity, n (%)
Non-Hispanic White (ref)
Non-Hispanic Black
Hispanic
Non-Hispanic Asian
Other
Family income to poverty ratio (FIPR)
quartiles, n (%)
≤ 1.02
>1.02 and < 1.82
1.82 to < 3.33
≥ 3.33 (ref)

p-value*
.006*
.507
<.001*
.018*
.150
.160

.012*
161 (26.31)
156 (25.49)
148 (24.18)
147 (24.02)

78 (33.33)
59 (25.21)
51 (21.79)
46 (19.66)

83 (21.96)
97 (25.66)
97 (25.66)
101 (26.72)

p-values for comparison between Liver Disease and No Liver Disease were conducted by t-test (continuous) or Chisquare test (categorical)
*p-value significant at α=0.05

Significant differences between adolescents with and without liver disease were seen for
screen time, weight status, gender, and FIPR quartiles. There was a significant effect of daily
screen time on liver disease status, t (610) = 2.74, p = .006, with adolescents who had evidence
of liver steatosis and/or fibrosis spending an average of 38.4 minutes (95% CI, 11.0 - 65.8) per
day longer on screens outside of school than those who did not have liver disease on FibroScan.
There was a significant difference in liver disease by weight status, (χ2 (1, N = 612) = 117.24, p <
.001); 63% of those with overweight/obesity had liver disease compared with 20% of those who
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were not overweight/obese. Participants with liver disease differed by sex, (χ2 (1, N = 612) =
5.59, p = .018) with 43% of males having liver disease, compared with 34% of females. The
frequency of participants with liver disease was significantly different by FIPR quartile (χ2 (3, N
= 612) = 11.02, p = .012). No significant differences were seen on bivariate analysis between
those with and without liver disease on imaging by days of physical activity per week.
In multivariable logistic regression (Table 3), after adjusting for age, sex, race, and FIPR,
the odds of liver steatosis and/or fibrosis on liver imagining were 8% higher for each additional
hour of daily screen time (aOR = 1.080; 95% CI = 1.015, 1.150; p = 0.016). Significant
associations with liver disease were also seen with male sex, Hispanic ethnicity (compared to
non-Hispanic White race), and the lowest FIPR quartile (compared to the highest FIPR quartile).
Physical activity was not significant when adjusted for in the regression of liver disease on
screen time.
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Table 3
Total Multivariable Logistic Regression for Liver Disease (Steatosis and/or Fibrosis) by Average
Daily Screen Time, NHANES 2017-2018 Participants Aged 12-17 Years, (N = 612)
Variable
Screen time (hours/day)
Physical activity (days/week)
Sex
Male
Female (referent)
Age (years at screening)
Race
Non-Hispanic White (ref)
Non-Hispanic Black
Hispanic
Non-Hispanic Asian
Other
Family income to poverty
ratio (FIPR) quartiles
≤ 1.02
>1.02 and < 1.82
1.82 to < 3.33
≥ 3.33 (ref)

Unstandardized
Coefficient
.077
-.009

Adjusted Odds Ratio (95% CIa)

.446
.022

1.562 (1.102-2.215)
1.023 (.919-1.137)

.275
.533
.331
.516

1.317 (.824-2.105)
1.704 (1.082-2.684)
1.392 (.758-2.558)
1.675 (.923-3.038)

.250
.022*
.287
.090

.728
.308
.068
-

2.070 (1.274-3.363)
1.360 (.827-2.239)
1.070 (.646-1.774)
-

.003*
.226
.792
-

1.080 (1.015-1.150)
.991 (.917-1.071)

p-value
.016*
.812
.012*
.680

Note. Covariates include gender, age, race, and family income to poverty ratio, and physical activity by quartiles.
a
CI is confidence interval
*p-value significant at α=0.05

Sobel’s test (unstandardized ab = .128, Z=2.053, p = .040) confirmed that
overweight/obesity significantly mediates the relationship between screen time and liver disease
(Figure 2). Screen time positively affect overweight/obese status (β=.045, z=4.287, p = .038)
and overweight/obese status, in turn is positively associated with liver disease (β=.226,
z=101.492, p < .001) (Table 4). Physical activity was not significant when adjusted for in the
regression of overweight/obesity status on screen time. After accounting for the mediating effect
of overweight/obese status, screen time has a small, not statistically significant direct effect, on
liver disease (β=.041, z=3.037, p = .081). Overweight/obese status accounted for 19.6% of the
total effect (Table 5).
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Figure 2
Mediation Pathway of the Relationship between Screen time and Liver Disease (Steatosis and/or
Fibrosis) as Mediated by Overweight/obesity in Adolescents Aged 12-17, NHANES 2017-2018,
(N = 612)*

Overweight/obesity
.045*

Screen time

.226*

Liver disease

.051* (.041)

Note. Standardized regression coefficients for the relationship between screen time and liver disease (steatosis
and/or fibrosis) as mediated by overweight/obesity. The direct effect between screen time and liver disease,
controlling for overweight/obesity, is in parentheses.
Adjustments were made for age, sex, race/ethnicity, and family income to poverty ratio quartile, and physical
activity for all regressions.
*p-value significant at α=0.05

Table 4
Mediation Path Estimates for the Relationship between Screen time and Liver Disease (Steatosis
and/or Fibrosis) as Mediated by Overweight/obesity, (N = 612).
Relationship
Screen time (a)  Overweight/obesity
Overweight/obesity (b)  Liver Disease
Screen time (c’)  Liver Disease
(Direct)
Screen time (c)  Liver Disease (Total)

Unstandardized
β
.065
1.968

Standardized
β
.045
.226

1.067 (1.003-1.134)
7.156 (4.880-10.494)

.038*
<.001*

.062

.041

1.064 (.992-1.097)

.081

.077

.051

1.080 (1.015-1.150)

.016*

aOR (95% CI)

p

Adjustments were made for age, sex, race/ethnicity, and family income to poverty ratio quartile, and physical
activity for all regressions.
a
CI is 95% confidence interval
*p-value significant at α=0.05
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Table 5
Mediation Path Effects for the Relationship between Screen time and Liver Disease (Steatosis
and/or Fibrosis) as Mediated by Overweight/obesity, (N = 612).

Indirect (ab)
Direct (c’)
Total (ab+c’)

Effect

Standardized estimate
.010
.041
.051

Mediation (%)
19.6

Discussion
It was hypothesized that screen time would positively predict liver steatosis and fibrosis
identified on FibroScan technology. While screen time did not have a significant direct effect on
the presence of liver disease, the average daily screen time in adolescents had an indirect effect
through BMI on imaging apparent liver disease. Overweight or obese status accounted for
19.6% of the total effect between screen time and imaging apparent liver disease. Other studies
have demonstrated that blood biomarkers, such as alanine aminotransferase (ALT) are not
sensitive for the detection of steatosis and fibrosis in adolescents (Ciardullo, Monti, & Perseghin,
2021). This is the first known study to evaluate the association between screen time and the
presence of MAFLD using liver imaging modalities.
Although other studies demonstrated prospectively that adolescents who are more
physically active are less likely to have liver adiposity on ultrasound (Anderson et al., 2016), the
present cross-sectional analysis did not reveal a significant difference in mean days per week
with 60 minutes or more of moderate to vigorous activity by liver disease status. This difference
in findings may reflect an information bias due to the self-reported exercise status in the present
study, whereas an accelerometer was used to measure physical activity in Anderson et al. (2016).
Other studies have shown that physical activity and screen time are both are independent
predictors of obesity (O'Brien, Issartel, & Belton, 2018). Sedentary screen usage and physical

SCREEN TIME, WEIGHT STATUS, AND LIVER DISEASE IN ADOLESCENTS

17

activity are not mutually exclusive and not necessarily functional opposites. Stemming the tide
of obesity and liver disease in adolescents may involve interventions directed at both decreasing
sedentary screen usage and increasing physical activity.
Insulin resistance is closely tied to the prevalence of overweight/obesity. Studies have
shown that increased screen time is associated with elevated insulin resistance in adolescents
(Hardy et al., 2010). Insulin resistance is furthermore associated with the incidence and
progression of fatty liver disorders (Manco, 2017). While the presence of obesity mediates the
relationship between increased screen time and liver disease, insulin sensitivity may be another
mediating factor along this pathway. Additionally, increased sedentary activity has been
associated with decreased activity of muscle lipoprotein lipase (LPL) which regulates blood lipid
concentration and carbohydrate metabolism (Park, Moon, Kim, Kong, & Oh, 2020). The present
study did not evaluate metabolic factors associated with obesity and fatty liver disease; however
further studies could evaluate the role of metabolic factors in the appearance of fatty liver
diseases on imaging in adolescents with high screen usage.
Limitations of this study include the following: 1) The study did not assess food
consumption or sleep patterns associated with screen use which may impact the observed
relationship between screen time and fatty liver disease. 2) Information bias could occur from
under-reporting of screen usage. Additionally, it is likely that screen usage is underestimated in
the study since the screen time questions excluded use during the school day. 3) Participants
were asked about their screen usage in the prior 30 days, which may not reflect usual or longterm screen usage. 4) Although multiple variables were controlled for in the analysis, it is
possible that others exist that may confound the results. 5) Since this was a cross-sectional
study, a temporal relationship between screen time and liver disease cannot be determined.
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The strengths of this study include the utilization of data from a nationally representative
sample of adolescents. Selection bias is unlikely as NHANES uses rigorous sampling methods.
The study results are generalizable to adolescents in the U.S., but potentially not to other
countries where cultural factors may influence screen usage, other obesity risk factors such as
diet and physical activity, and the prevalence of fatty liver disease.
Conclusion
Increasing screen time is associated with liver steatosis and fibrosis in U.S. adolescents.
This relationship is significantly mediated by overweight/obese status. Fatty liver disease is
increasing in prevalence in teens in the U.S., mirroring the increases in screen time and
overweight/obesity. This is concerning because fatty liver diseases progress in severity over
time and the morbidity and mortality associated with chronic liver diseases is expected to
increase as cohorts of adolescents age into adulthood. Non-invasive FibroScan testing may see
wider application in adolescents to diagnosis liver disease and monitor progression.
Longitudinal studies could assess the effect of screen time on metabolic risk factors which
impact liver disease in adolescents. Currently, there are no evidence-based medical interventions
for fatty liver disease in adolescents. Treatment is focused on encouraging a healthy diet and
increased physical activity. Reduction of screen time is another lifestyle target to decrease
MAFLD by reducing the prevalence of obesity.
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